Alzamend Neuro Overview

Alzamend Neuro Research & Development

Research & Development expenses for ALZN.

Quarterly R&D Expenses

$1.28M

↑ 185.98% YoY

As of Jan 31, 2026

Annual R&D Expenses (TTM)

$3.65M

↑ 217.53% YoY

Trailing 12 months ending Jan 31, 2026

Average R&D Expenses (Comparison Companies)

Research & Development History

Research & Development Comparison

Annual Research & Development Growth Rate (%)

Annual Research & Development Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin